General Commentary
Accepted on 31 Oct 2025
ABLIM1: A novel oncogenic E3 ligase in colorectal cancer
in Molecular and Cellular Oncology
General Commentary
Accepted on 31 Oct 2025
in Molecular and Cellular Oncology
Original Research
Accepted on 31 Oct 2025
in Drug Metabolism and Transport
Review
Accepted on 31 Oct 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 31 Oct 2025
in Politics of Technology
Review
Accepted on 31 Oct 2025
in Biomaterials and Bio-Inspired Materials
Clinical Trial
Accepted on 31 Oct 2025
in Drug Metabolism and Transport
Original Research
Accepted on 31 Oct 2025
in Pediatric Critical Care
Original Research
Accepted on 31 Oct 2025
in Mechanics of Materials
Original Research
Accepted on 31 Oct 2025
in Hepatobiliary Diseases
Case Report
Accepted on 31 Oct 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 31 Oct 2025
in Molecular Innate Immunity
Case Report
Accepted on 31 Oct 2025
in Precision Medicine
Editorial
Accepted on 31 Oct 2025
in Nanobiotechnology
Review
Accepted on 31 Oct 2025
in Pediatric Oncology
Original Research
Accepted on 31 Oct 2025
in Neurorehabilitation
Original Research
Accepted on 31 Oct 2025
in Sport Psychology